MANGANO, KATIA DOMENICA
 Distribuzione geografica
Continente #
NA - Nord America 6.565
EU - Europa 2.292
AS - Asia 2.144
SA - Sud America 554
AF - Africa 481
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.047
Nazione #
US - Stati Uniti d'America 6.389
IT - Italia 919
CN - Cina 897
SG - Singapore 881
BR - Brasile 494
IE - Irlanda 476
CI - Costa d'Avorio 335
UA - Ucraina 334
DE - Germania 160
CA - Canada 145
RU - Federazione Russa 134
KR - Corea 100
SN - Senegal 99
VN - Vietnam 81
SE - Svezia 61
GB - Regno Unito 42
IN - India 38
FI - Finlandia 33
AR - Argentina 24
PL - Polonia 22
BD - Bangladesh 21
MX - Messico 21
FR - Francia 20
IR - Iran 17
BE - Belgio 16
UZ - Uzbekistan 16
TR - Turchia 14
EC - Ecuador 13
IQ - Iraq 13
AT - Austria 12
CH - Svizzera 12
HK - Hong Kong 12
NL - Olanda 12
JP - Giappone 11
NG - Nigeria 10
GR - Grecia 8
PK - Pakistan 8
MA - Marocco 7
MK - Macedonia 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
ES - Italia 6
VE - Venezuela 6
GE - Georgia 5
LB - Libano 5
TN - Tunisia 5
CO - Colombia 4
CZ - Repubblica Ceca 4
EU - Europa 4
PY - Paraguay 4
AO - Angola 3
BG - Bulgaria 3
CL - Cile 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
KE - Kenya 3
LT - Lituania 3
PE - Perù 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
ID - Indonesia 2
IL - Israele 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
RO - Romania 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
HU - Ungheria 1
KH - Cambogia 1
LI - Liechtenstein 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RW - Ruanda 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 12.047
Città #
Dallas 2.077
Santa Clara 797
Singapore 534
Dublin 476
Chandler 464
Jacksonville 402
Abidjan 335
Chicago 272
Catania 259
Hefei 231
Houston 225
Boardman 213
Ashburn 151
Cambridge 127
Lawrence 127
Andover 124
Beijing 122
Nanjing 113
Civitanova Marche 107
Toronto 102
Seoul 100
Dakar 99
Des Moines 72
San Mateo 59
Wilmington 51
Los Angeles 48
Grafing 47
Nanchang 44
Saint Petersburg 43
Palermo 40
Hebei 33
São Paulo 29
Bremen 28
Ho Chi Minh City 26
Ottawa 26
Tianjin 24
Jiaxing 23
Munich 23
Sant'Antonio Abate 23
Rome 22
Columbus 21
Changsha 20
Lappeenranta 20
The Dalles 20
Falls Church 19
Vercelli 18
Dong Ket 17
Rio de Janeiro 17
Brussels 16
Shenyang 16
Brooklyn 15
Chiaramonte Gulfi 15
Maletto 15
Nizza di Sicilia 15
Washington 15
Boston 14
Council Bluffs 14
Moscow 14
New York 14
San Francisco 13
Augusta 11
Hong Kong 11
Messina 11
Abuja 10
Ardabil 10
Atlanta 10
Belo Horizonte 10
Campinas 10
Hanoi 10
Leawood 10
London 10
Tokyo 10
Turku 10
Warsaw 10
Acireale 9
Amsterdam 9
Guangzhou 9
Milan 9
Phoenix 9
Ragusa 9
Bronte 8
Dearborn 8
Hangzhou 8
Jinan 8
Licata 8
Mascalucia 8
Mumbai 8
Naples 8
Stockholm 8
Baghdad 7
Brasília 7
Curitiba 7
Dhaka 7
Padova 7
Pozzallo 7
Recife 7
Skopje 7
Vienna 7
Monmouth Junction 6
Mountain View 6
Totale 8.790
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 364
Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. 263
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 168
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 162
Rifamycin SV: evaluation of the activity in DNB-induced colitis in rats and on IFNγ production in ConA-stimulated rat splenocytes 158
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 151
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 144
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 138
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 133
Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens 130
COMPOSIZIONE PER PREVENIRE O TRATTARE LA SINDROME DELL'OVAIO POLICISTICO E LA SINTOMATOLOGIA CORRELATA 126
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 126
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 125
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 124
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 124
Composition for the prevention or treatment of polycystic ovary syndrome and its related sumptoms 121
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 121
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 120
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 119
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 115
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 115
Emerging therapeutic targets for the treatment of hepatic fibrosis 112
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 111
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 111
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 110
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 109
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 107
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 107
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 107
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 107
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 105
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 105
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 104
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 104
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 103
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 103
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 103
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 102
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies 101
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study 101
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 101
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 100
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 100
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 98
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 98
Detection of BRAF gene mutation in primary choroidal melanoma tissue 93
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 93
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma 93
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus 83
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo 82
Immunomodulatory properties of cefaclor: In vivo effect on cytokines release and lymphoprolipherative response on rat 81
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 80
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 78
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 78
Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures 75
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 74
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 73
Sponge-like macroporous cyclodextrin-based cryogels for controlled drug delivery 73
The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis 73
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 73
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 73
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy 73
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells/MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN 73
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study 72
The immunobiology of apotransferrin in type 1 diabetes 72
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 72
The dichotomic role of macrophage migration inhibitory factor in neurodegeneration 72
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND 71
Bone Marrow-Derived Mesenchymal Stem Cells To Augment Liver Regeneration in a Preclinical Model of Acute Liver Failure in Rats 71
Therapeutic potential of carbon monoxide in multiple sclerosis 70
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells 70
Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis 70
Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma 70
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 69
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 69
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? 69
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 68
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 68
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14 68
The role of macrophage migration inhibitory factor in Alzheimer′s disease: Conventionally pathogenetic or unconventionally protective? 68
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis 67
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 67
Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties 67
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 67
Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL 66
Expression of DNA methylation genes in secondary progressive multiple sclerosis 66
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 66
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 66
Cytotoxic and Immune-Sensitizing Properties of Nitric Oxide-Modified Saquinavir in iNOS-Positive Human Melanoma Cells 65
Therapeutic effects of single administration of Cyclophosphamide in rat experimental autoimmune neuritis, a pre-clinical model of autoimmune peripheral neuropathies 65
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 65
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 65
Novel components of the human metabolome: The identification, characterization and anti-inflammatory activity of two 5-androstene tetrols 65
In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models 64
Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis 64
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 63
Protection against murine endotoxemia by treatment with Ruta Chalepensis L., a plant with anti-inflammatory properties 63
Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology 62
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus 62
Ischemia/reperfusion- models and modulations 62
Totale 9.563
Categoria #
all - tutte 44.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021582 0 0 0 17 189 15 81 1 88 1 153 37
2021/2022965 98 125 10 21 153 25 138 32 75 9 27 252
2022/20231.621 142 80 27 145 135 250 14 297 392 32 56 51
2023/2024880 55 110 46 64 31 284 8 79 5 30 92 76
2024/20253.278 41 471 192 167 768 319 185 102 230 289 288 226
2025/20263.414 449 1.231 1.480 254 0 0 0 0 0 0 0 0
Totale 12.273